PH17207A - New imidazo-rifamycin derivatives with antibacterial utility - Google Patents

New imidazo-rifamycin derivatives with antibacterial utility

Info

Publication number
PH17207A
PH17207A PH25656A PH25656A PH17207A PH 17207 A PH17207 A PH 17207A PH 25656 A PH25656 A PH 25656A PH 25656 A PH25656 A PH 25656A PH 17207 A PH17207 A PH 17207A
Authority
PH
Philippines
Prior art keywords
rifamycin derivatives
new imidazo
antibacterial utility
antibacterial
utility
Prior art date
Application number
PH25656A
Other languages
English (en)
Inventor
Egidio Marchi
Lauretta Montecchi
Original Assignee
Alfa Farmaceutici Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alfa Farmaceutici Spa filed Critical Alfa Farmaceutici Spa
Publication of PH17207A publication Critical patent/PH17207A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/22—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains four or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
PH25656A 1980-05-22 1981-05-20 New imidazo-rifamycin derivatives with antibacterial utility PH17207A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT03429/80A IT1154655B (it) 1980-05-22 1980-05-22 Derivati imidazo-rifamicinici metodi per la loro preparazione e loro uso come sostanza ad azione antibatterica

Publications (1)

Publication Number Publication Date
PH17207A true PH17207A (en) 1984-06-19

Family

ID=11107198

Family Applications (2)

Application Number Title Priority Date Filing Date
PH25656A PH17207A (en) 1980-05-22 1981-05-20 New imidazo-rifamycin derivatives with antibacterial utility
PH26842A PH18704A (en) 1980-05-22 1982-02-09 Method of treatment using inidazo-rifamycin derivatives with antibacterial utility

Family Applications After (1)

Application Number Title Priority Date Filing Date
PH26842A PH18704A (en) 1980-05-22 1982-02-09 Method of treatment using inidazo-rifamycin derivatives with antibacterial utility

Country Status (25)

Country Link
US (1) US4341785A (enExample)
JP (1) JPS5711987A (enExample)
AR (1) AR226212A1 (enExample)
AT (1) AT373599B (enExample)
AU (1) AU537093B2 (enExample)
BE (1) BE888895A (enExample)
CA (1) CA1142518A (enExample)
CH (1) CH648037A5 (enExample)
DE (1) DE3120460A1 (enExample)
DK (1) DK157876C (enExample)
EG (1) EG14891A (enExample)
ES (1) ES502906A0 (enExample)
FI (1) FI69467C (enExample)
FR (1) FR2482967A1 (enExample)
GB (1) GB2079270B (enExample)
GR (1) GR75640B (enExample)
IE (1) IE51204B1 (enExample)
IT (1) IT1154655B (enExample)
LU (1) LU83376A1 (enExample)
NL (1) NL187022C (enExample)
NO (1) NO155622C (enExample)
PH (2) PH17207A (enExample)
PT (1) PT73064B (enExample)
SE (1) SE453089B (enExample)
ZA (1) ZA813430B (enExample)

Families Citing this family (77)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1199374B (it) 1984-05-15 1988-12-30 Alfa Farmaceutici Spa Processo per la preparazione di pirido-imidazo-rifamicine
IT1264494B1 (it) * 1993-03-23 1996-09-24 Alfa Wassermann Spa Uso di rifaximin e di formulazioni che la contengono nel trattamento delle dispepsie gastriche originate da helicobacter
US7048906B2 (en) * 1995-05-17 2006-05-23 Cedars-Sinai Medical Center Methods of diagnosing and treating small intestinal bacterial overgrowth (SIBO) and SIBO-related conditions
US6861053B1 (en) 1999-08-11 2005-03-01 Cedars-Sinai Medical Center Methods of diagnosing or treating irritable bowel syndrome and other disorders caused by small intestinal bacterial overgrowth
US5981522A (en) * 1995-09-01 1999-11-09 Kaneka Corporation Treatment of disease caused by infection of Helicobacter
CA2230649C (en) * 1997-02-28 2007-11-06 Kaneka Corporation Medicine for a disease caused by infection of helicobacter
EP1453837A4 (en) * 2001-11-21 2007-11-07 Activbiotics Inc TARGETED THERAPEUTIC AGENTS AND USES THEREOF
US7078399B2 (en) * 2001-12-13 2006-07-18 Activbiotics, Inc. Sulfhydryl rifamycins and uses thereof
ES2385477T3 (es) * 2002-11-05 2012-07-25 Fadim S.R.L. Liberación continua y controlada de rifaximina
US7820652B2 (en) * 2003-09-24 2010-10-26 Activbiotics Pharma, Llc Regimen for the administration of rifamycin-class antibiotics
US7902206B2 (en) * 2003-11-07 2011-03-08 Alfa Wassermann, S.P.A. Polymorphic forms α, β and γ of rifaximin
US20080262024A1 (en) * 2003-11-07 2008-10-23 Giuseppe Claudio Viscomi Rifaximin compositions and method of use
US7923553B2 (en) * 2003-11-07 2011-04-12 Alfa Wassermann, S.P.A. Processes for the production of polymorphic forms of rifaximin
US7906542B2 (en) * 2004-11-04 2011-03-15 Alfa Wassermann, S.P.A. Pharmaceutical compositions comprising polymorphic forms α, β, and γ of rifaximin
ITMI20032144A1 (it) * 2003-11-07 2005-05-08 Alfa Wassermann Spa Forme polimorfe di rifaximina, processi per ottenerle e
US7256187B2 (en) * 2004-03-10 2007-08-14 Cumbre Pharmaceuticals Inc. Rifamycin C-11 oxime derivatives effective against drug-resistant microbes
US7265107B2 (en) * 2004-03-10 2007-09-04 Cumbre Pharmaceuticals Inc. Rifamycin C-11 oxime cyclo derivatives effective against drug-resistant microbes
US7202246B2 (en) * 2004-06-09 2007-04-10 Cumbre Pharmaceuticals Inc. Spiro-rifamycin derivatives targeting RNA polymerase
US20060210492A1 (en) * 2005-03-02 2006-09-21 Kodsi Robert E Use of rifaximin for treatment and prevention of periodontal conditions
US8003118B2 (en) * 2005-03-02 2011-08-23 Kodsi Robert E Use of rifaximin for the prevention of aspiration pneumonia and/or sepsis
US20060210483A1 (en) * 2005-03-02 2006-09-21 Kodsi Robert E Non-systemic antibiotic formulations and related method of use and treatment of upper respiratory infections
DK1698630T3 (da) 2005-03-03 2014-12-08 Alfa Wassermann Spa Nye polymorfe former af rifaximin, fremgangsmåde for deres fremstilling og anvendelse deraf i de medicinske præparater
ITBO20050123A1 (it) 2005-03-07 2005-06-06 Alfa Wassermann Spa Formulazioni farmaceutiche gastroresistenti contenenti rifaximina
EA016059B1 (ru) 2005-08-11 2012-01-30 Тарганта Терапьютикс Инк. Фосфонированные рифамицины и их применение для профилактики и лечения костных и суставных инфекций
US8987292B2 (en) 2006-03-09 2015-03-24 Salix Pharmaceuticals, Ltd. Rifaximin anti-rectal dysfunction preparation
ES2538478T3 (es) 2006-08-02 2015-06-22 Salix Pharmaceuticals, Inc. Métodos para el tratamiento de enteritis por radiación
ITMI20061692A1 (it) 2006-09-05 2008-03-06 Alfa Wassermann Spa Uso di polioli per ottenere forme polimorfe stabili di rifaximina
NZ575550A (en) * 2006-09-22 2011-12-22 Cipla Ltd Rifaximin
US20080161337A1 (en) * 2007-01-03 2008-07-03 Leonard Weinstock Use of Rifaximin for the Treatment of Chronic Prostatitis
US20080159987A1 (en) * 2007-01-03 2008-07-03 Leonard Weinstock Use of Rifaximin for the Treatment of Restless Legs Syndrome
ITMI20071241A1 (it) * 2007-06-20 2008-12-21 Solmag S P A Processo per la preparazione di rifaximina amorfa e rifaximina amorfa cosi' ottenuta
EP3714878B1 (en) 2007-07-06 2022-01-19 Lupin Limited Pharmaceutical compositions of rifaximin
WO2009008005A1 (en) 2007-07-06 2009-01-15 Lupin Limited Pharmaceutical compositions of rifaximin
US7709634B2 (en) * 2007-09-20 2010-05-04 Apotex Pharmachem Inc. Amorphous form of rifaximin and processes for its preparation
UA101829C2 (uk) 2008-02-25 2013-05-13 Саликс Фармасьютикалз, Лтд. ФОРМА η РИФАКСИМІНУ І ЇЇ ЗАСТОСУВАННЯ В ТЕРАПЕВТИЧНІЙ ПРАКТИЦІ
US8486956B2 (en) 2008-02-25 2013-07-16 Salix Pharmaceuticals, Ltd Forms of rifaximin and uses thereof
US11779571B2 (en) 2008-02-26 2023-10-10 Salix Pharmaceuticals, Inc. Methods for treating irritable bowel syndrome (IBS)
ES2727728T3 (es) 2008-02-26 2019-10-18 Salix Pharmaceuticals Ltd Métodos para el tratamiento del síndrome del intestino irritable
HRP20140939T1 (hr) 2008-05-07 2014-11-21 Salix Pharmaceuticals, Ltd. Davanje preparata za äśišä†enje crijeva i antibiotika za lijeäśenje bolesti crijeva
EP2324041A4 (en) 2008-08-13 2012-06-13 Targanta Therapeutics Corp PHOSPHONIZED RIFAMYCINS AND ITS APPLICATION FOR THE PREVENTION AND TREATMENT OF BONE AND JOINT INFECTIONS
JP5567484B2 (ja) 2008-09-26 2014-08-06 あすか製薬株式会社 機能性消化管障害の予防及び／又は治療剤
MX364102B (es) 2008-10-02 2019-04-12 Salix Pharmaceuticals Ltd Medicamentos para usarse en el tratamiento de la encefalopatía hepática.
US12285414B2 (en) 2008-10-02 2025-04-29 Salix Pharmaceuticals, Inc. Methods of treating hepatic encephalopathy
ES2718614T3 (es) 2008-12-10 2019-07-03 Cipla Ltd Complejos de rifaximina
IT1397617B1 (it) * 2009-04-20 2013-01-18 Alfa Wassermann Spa Nuovi derivati della rifamicina
EP3964066A1 (en) 2009-06-02 2022-03-09 Salix Pharmaceuticals, Ltd. Methods of treating hepatic encephalopathy
MX2012002895A (es) 2009-09-13 2012-05-22 Salix Pharmaceuticals Ltd Metodos para tratar el sindrome de intestino irritado (ibs).
KR20200100215A (ko) 2009-10-27 2020-08-25 루핀 리미티드 리팍시민의 고형 분산물
JP2013511570A (ja) 2009-11-23 2013-04-04 シプラ・リミテッド 局所用泡沫組成物
WO2011080691A1 (en) 2009-12-28 2011-07-07 Silvio Massimo Lavagna Method for the production of amorphous rifaximin
JP5896380B2 (ja) 2010-02-18 2016-03-30 サリックス ファーマスーティカルズ，リミテッド 感染症を治療するための方法
IT1398550B1 (it) 2010-03-05 2013-03-01 Alfa Wassermann Spa Formulazioni comprendenti rifaximina utili per ottenere un effetto prolungato nel tempo
WO2011110930A2 (en) 2010-03-10 2011-09-15 Lupin Limited Rifaximin ready-to-use suspension
PH12013500082B1 (en) 2010-07-12 2019-06-28 Salix Pharmaceuticals Ltd Formulations of rifaximin and uses thereof
WO2012035544A2 (en) 2010-09-13 2012-03-22 Sequent Scientific Ltd. A novel polymorphic form of rifaximin and process for its preparation
EA201391171A1 (ru) 2011-02-11 2014-11-28 Сэликс Фармасьютиклз, Лтд. Формы рифаксимина и их применение
WO2012150561A1 (en) 2011-05-02 2012-11-08 Ranbaxy Laboratories Limited Rifaximin dimethylformamide solvate
ITMI20110890A1 (it) 2011-05-19 2012-11-20 A M S A Anonima Materie Sint & Affini S P A Polimorfo di rifaximina e processo per la sua preparazione
ITBO20110461A1 (it) 2011-07-29 2013-01-30 Alfa Wassermann Spa Composizioni farmaceutiche comprendenti rifaximina, processi per la loro preparazione e loro uso nel trattamento di infezioni vaginali.
RU2496475C2 (ru) 2011-10-26 2013-10-27 Александр Васильевич Иващенко Фармацевтическая композиция и набор для лечения бактериальных инфекций
EP2773205B1 (en) 2011-11-02 2024-05-22 Salix Pharmaceuticals, Inc. Rifaximin for retreating diarrhea-predominant irritable bowel syndrome
EP2807148A4 (en) * 2012-01-25 2015-04-08 Salix Pharmaceuticals Ltd RIFAXIMIN DERIVATIVE AND USES THEREOF
ITBO20120368A1 (it) 2012-07-06 2014-01-07 Alfa Wassermann Spa Composizioni comprendenti rifaximina e amminoacidi, cristalli di rifaximina derivanti da tali composizioni e loro uso.
WO2014091432A1 (en) 2012-12-12 2014-06-19 Ranbaxy Laboratories Limited Pharmaceutical compositions of rifaximin
EP2971062A2 (en) 2013-03-15 2016-01-20 ALFA WASSERMANN S.p.A. Method for diagnosing vaginal infections
JP2016510809A (ja) 2013-03-15 2016-04-11 アルファ ワッセルマン ソシエタ ペル アチオニＡｌｆａ Ｗａｓｓｅｒｍａｎｎ Ｓ．Ｐ．Ａ． 膣感染症の治療に使用するためのリファキシミン
PT2983647T (pt) 2013-04-12 2020-11-09 Alfasigma Spa Administração de aine e composições, métodos e sistemas relacionados
US9018225B1 (en) 2013-07-26 2015-04-28 Novel Laboratories Rifaximin crystalline forms and methods of preparation thereof
ES2621557T3 (es) 2014-03-31 2017-07-04 Euticals S.P.A. Mezcla polimórfica de rifaximina y su uso para la preparación de formulaciones sólidas
WO2015159275A2 (en) * 2014-04-19 2015-10-22 Granules India Limited An improved process for the preparation of rifamycin derivatives
CA2947962C (en) 2014-05-04 2024-01-16 Salix Pharmaceuticals, Inc. Ibs microbiota and uses thereof
JP6576953B2 (ja) 2014-05-12 2019-09-18 アルファシグマ ソシエタ ペル アチオニ リファキシミンの新規溶媒和物結晶形、生成物、組成物及びそれらの使用
EP2982764A1 (en) 2014-08-05 2016-02-10 ALFA WASSERMANN S.p.A. Identification of vaginal bacteria
US9988398B2 (en) 2016-06-07 2018-06-05 Cadila Healthcare Limited Crystalline form of rifaximin and process for its preparation
EP4137132A1 (en) 2016-09-30 2023-02-22 Salix Pharmaceuticals, Inc. Solid dispersion forms of rifaximin
IT201700091912A1 (it) * 2017-08-08 2019-02-08 Biofer Spa Nuove pirido-imidazo rifamicine
RU2020102511A (ru) * 2017-06-26 2021-07-27 Биофер С.П.А. Соединения пиридо-имидазо рифамицина в качестве антибактериального средства

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE273377C (enExample) *
AT273377B (de) * 1967-03-01 1969-08-11 Lepetit Spa Verfahren zur Herstellung von neuen Rifamycinen
AT344898B (de) * 1975-06-13 1978-08-10 Archifar Ind Chim Trentino Verfahren zur herstellung neuer rifamycin-verbindungen
DK345977A (da) * 1976-09-30 1978-03-31 Archifar Ind Chim Trentino G rifamycinforbindelser og fremgangsmaade til deres fremstillin
CH629212A5 (it) * 1976-10-18 1982-04-15 Erba Farmitalia Procedimento per la preparazione di composti di rifamicina.
CH633014A5 (en) * 1978-06-09 1982-11-15 Erba Farmitalia Rifamycin compounds

Also Published As

Publication number Publication date
JPS6123192B2 (enExample) 1986-06-04
DK157876B (da) 1990-02-26
IE51204B1 (en) 1986-10-29
NL187022C (nl) 1991-05-01
FI69467B (fi) 1985-10-31
ATA222781A (de) 1983-06-15
LU83376A1 (fr) 1981-09-11
AU7065581A (en) 1981-11-26
FR2482967A1 (fr) 1981-11-27
EG14891A (en) 1985-12-31
DE3120460C2 (enExample) 1990-12-13
NL8102290A (nl) 1981-12-16
FR2482967B1 (enExample) 1985-03-29
IT8003429A0 (it) 1980-05-22
FI69467C (fi) 1986-02-10
GB2079270A (en) 1982-01-20
FI811565L (fi) 1981-11-23
JPS5711987A (en) 1982-01-21
GB2079270B (en) 1984-01-18
DK157876C (da) 1990-07-30
AT373599B (de) 1984-02-10
GR75640B (enExample) 1984-08-02
BE888895A (fr) 1981-09-16
AR226212A1 (es) 1982-06-15
CH648037A5 (de) 1985-02-28
PT73064B (en) 1982-07-05
SE8103216L (sv) 1981-11-23
DK224781A (da) 1981-11-23
PH18704A (en) 1985-09-05
ZA813430B (en) 1982-06-30
AU537093B2 (en) 1984-06-07
IT1154655B (it) 1987-01-21
DE3120460A1 (de) 1982-03-11
ES8203388A1 (es) 1982-04-01
NO155622B (no) 1987-01-19
ES502906A0 (es) 1982-04-01
IE811139L (en) 1981-11-22
CA1142518A (en) 1983-03-08
NO155622C (no) 1987-04-29
PT73064A (en) 1981-06-01
US4341785A (en) 1982-07-27
SE453089B (sv) 1988-01-11
NL187022B (nl) 1990-12-03
NO811731L (no) 1981-11-23

Similar Documents

Publication Publication Date Title
PH17207A (en) New imidazo-rifamycin derivatives with antibacterial utility
JPS5625111A (en) Antibacterial
PH19489A (en) Aminoalkylfuran derivatives
JPS56157071A (en) Photocell with wide area
JPS56156231A (en) Antibacterial composition
PT72965A (en) 4-alkylphenylpropylamine derivatives
GB2067989B (en) Bis-moranoline derivatives
JPS5640236A (en) Reembedding siliconnwafer groove
GB8324990D0 (en) 3-aminopropoxyphenyl derivatives
IL62838A0 (en) New phenylpropargylamine derivatives
EP0054756A3 (en) Antibacterial benzylpyrimidines
ZA81432B (en) Thiophene derivatives
HK100387A (en) 1-phenethylimidazole derivatives
GB2052621B (en) Door-closer with detent means
AU526593B2 (en) Tetrahydropyranyl derivatives with antibacterial property
NZ190675A (en) Furonaphthyridines with antibacterial properties
GB2039316B (en) Glazing
JPS5686168A (en) Antibacterial
JPS5652801A (en) Daylight utility illuminator
GB2055942B (en) Double glazing
JPS5732220A (en) Antibacterial
ZA814584B (en) Compounds with antibiotic activity
CA47569S (en) Utility building
BG31418A1 (en) Impactresistant poljsterene composition with diminvated combustibilitj
PH14854A (en) Utility cart